How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
Int J Cardiol
; 365: 61-68, 2022 10 15.
Article
in En
| MEDLINE
| ID: mdl-35905826
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Technology Assessment, Biomedical
Type of study:
Guideline
/
Health_technology_assessment
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Int J Cardiol
Year:
2022
Document type:
Article